Yukinori Take Selected Research

EP4 Subtype Prostaglandin E Receptors

1/2020	Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
1/2014	Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukinori Take Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 01/2013
2	Breast Neoplasms (Breast Cancer) 01/2014 - 01/2013
1	Disease Progression 01/2020
1	Ductal Carcinoma 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2013

Drug/Important Bio-Agent (IBA)

3	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2020 - 01/2013
2	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2013
2	EP4 Subtype Prostaglandin E ReceptorsIBA 01/2020 - 01/2014
1	Therapeutic UsesIBA 01/2020
1	AntigensIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2014
1	frondoside AIBA 01/2014
1	Aldehyde DehydrogenaseIBA 01/2014
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2014
1	AH 23848IBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2013
1	ProstaglandinsIBA 01/2013

Therapy/Procedure

1	Immunotherapy 01/2020
1	Therapeutics 01/2020
1	Transplantation 01/2014
1	Oral Administration 01/2013